Navigation Links
Agencourt Genomic Services is Key Collaborator in New Research That Further Defines Landscape of Breast and Colon Cancers
Date:10/17/2007

Johns Hopkins Report Represents Major Step in Cancer Genome Research

FULLERTON, Calif., Oct. 17 /PRNewswire-FirstCall/ -- Agencourt Bioscience Corporation, a Beckman Coulter company, announced today that its Genomic Services played an important role in a newly released study from Johns Hopkins Kimmel Cancer Center. The study follows a major report last year that announced the discovery of 200 genes linked to breast and colon cancers. This second report completes the study of the vast majority of protein-coding genes and catalogs the genetic changes that occur during tumorigenesis. Three Agencourt individuals -- James Hartigan, Douglas R. Smith and Erick Suh -- were among the authors of the study, "The Genomic Landscape of Human Breast and Colorectal Cancers," published in Science Express last week.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

All of the sequencing work and data generation for the study were done by Agencourt's Genomic Services, which has a long-standing relationship with the Johns Hopkins Kimmel Cancer Center scientists.

According to a news release issued by the Johns Hopkins Kimmel Cancer Center, scientists involved in the study found that most cancer-causing gene mutations are quite diverse and can vary from person to person. Of the 70 to 80 genes that are mutated in an individual cancer, about 15 are likely to contribute to the cancer's key characteristics, and most of these genes are different for each patient. With no more higher-frequency mutations (such as p53) on the horizon, researchers can focus on these less-commonly mutated genes and the complicated protein pathways that link them. Personalized cancer genomic research paves the way for tailored therapies and diagnostics focusing on the alterations identified in a particular patient's cancer.

"The research findings have important implications in the development of personal genomics, including molecular diagnostic tests, which are of great interest to Beckman Coulter," commented Erick Suh, Genomic Services director for Agencourt. "As the leading provider of DNA sequencing services, we have developed strong relationships with leading cancer research teams such as Johns Hopkins and are proud to contribute to these scientific advancements."

Agencourt Bioscience Corporation, a wholly owned subsidiary of Beckman Coulter, is a leading provider of nucleic acid purification products and genomic services for life science research. The company's products and services are based on the patented Agencourt SPRI(R) (Solid Phase Reversible Immobilization) paramagnetic bead-based technology.

Beckman Coulter, Inc., based in Fullerton, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represents more than 75 percent of the company's 2006 annual revenue of $2.53 billion. For more information, visit http://www.beckmancoulter.com.

To view the Johns Hopkins Kimmel Cancer Center news release please copy and paste the following link into your browser: http://www.hopkinskimmelcancercenter.org/news/index.cfm?documentid=931&news typ e=News%20Releases&action=showthisitem

Contacts: Jennifer Dahlgren, Dahlgren Communications

Phone: (530) 265-0538

E-mail: jdahlgren@gv.net

Lynn Doucette-Stamm, Ph.D. Agencourt Bioscience Corporation

Phone: (978) 867-2670

E-mail: ldoucette@agencourt.com


'/>"/>
SOURCE Agencourt Bioscience Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Fast and Easy Isolation of PCR-Ready Genomic DNA from Whole Blood
2. New Protocols for Isolating High- Molecular-Weight Genomic DNA
3. Easily Amplify Genomic DNA with Long-Distance PCR
4. Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood Mini Kit
5. Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood Mini Kit
6. Isolation of Genomic DNA from Saliva Using the Perfect gDNA Blood Mini Kit
7. Mouse Tail Genomic DNA Isolation Protocol(1)
8. Genomic DNA Isolation Protocol(1,2,3)
9. Genomic DNA Extraction from Buccal Swabs Using the Perfect gDNA Blood Mini Kit
10. Genomic DNA Extraction from Buffy Coat Using the Perfect gDNA Blood Mini Kit
11. Isolation of Genomic DNA from Saliva Using the Perfect gDNA Blood Mini Kit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... February 28, 2017 , ... RoviSys, a leading independent provider ... has joined the Cisco® Digital Solutions Integrator Program. As a member of this ... that addresses Industrial IT and Business IT in manufacturing environments. , John ...
(Date:2/28/2017)... ... February 28, 2017 , ... Over 8,000 recognized rare diseases afflict an ... webinar on March 7, DrugDev will gather international experts to share challenges ... area. , Webinar: Overcoming the Challenges of Rare Disease Clinical Trials, Date: March ...
(Date:2/28/2017)... ... February 28, 2017 , ... ... therapeutics from millions-diverse immune repertoires, today announced a strategic partnership with Trianni, ... engineered to express human antibodies. The partnership will use GigaGen technology to discover ...
(Date:2/28/2017)... LONDON and PHILADELPHIA , ... Pharma"), a privately held biopharmaceutical company focusing on debilitating ... treatment options, today announced that the company joins with ... leaders in patient advocacy and support around the world ... to highlight the unique challenges and needs of the ...
Breaking Biology Technology:
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet Holdings, ... musculoskeletal healthcare, will present at the LEERINK Partners 6th ... Palace Hotel on Wednesday, February 15, 2017 at 10 ... of the presentation can be accessed at http://wsw.com/webcast/leerink28/zbh ... the conference via Zimmer Biomet,s Investor Relations website at ...
(Date:2/6/2017)... DENVER , Feb. 6, 2017 ... national security are driving border authorities to continue ... Acuity reports there are 2143 Automated Border Control ... Kiosks currently deployed at more than 163 ports ... between 2013 to 2016 achieving a combined CAGR ...
(Date:2/3/2017)... , Feb. 3, 2017 A new ... Identity Strategy Partners, LLP (IdSP) . Designed to fill ... the complex identity market, founding partners Mark Crego ... 35 combined years just in identity expertise that span ... and non-profit leadership. The Crego-Kephart combined expertise has a ...
Breaking Biology News(10 mins):